REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $133,958,163 | +3.5% | 4,839,529 | 0.0% | 40.59% | -7.8% |
Q2 2023 | $129,457,401 | +23.5% | 4,839,529 | 0.0% | 44.00% | +0.6% |
Q1 2023 | $104,824,198 | +5.0% | 4,839,529 | +15.5% | 43.76% | +10.2% |
Q4 2022 | $99,794,581 | +20.8% | 4,189,529 | 0.0% | 39.70% | +48.8% |
Q3 2022 | $82,618,000 | +7.6% | 4,189,529 | +6.3% | 26.68% | +3.0% |
Q2 2022 | $76,781,000 | -23.6% | 3,939,529 | 0.0% | 25.90% | -9.7% |
Q1 2022 | $100,497,000 | +34.5% | 3,939,529 | +32.7% | 28.69% | +45.8% |
Q4 2021 | $74,710,000 | – | 2,968,214 | – | 19.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |